Survivin is a novel target of CD44-promoted breast tumor invasion

Mohamed E. Abdraboh, Rajiv L. Gaur, Andrew D. Hollenbach, Dane Sandquist, Madhwa H G Raj, Allal Ouhtit

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The hyaluronan (HA) receptor CD44 plays an essential role in cellcell or cellextracellular matrix communications and is a bioactive signal transmitter. Although a number of studies have described the function of CD44 in breast cancer (BC) metastasis, the underlying mechanisms have yet to be determined. By using a validated tetracycline-off-regulated CD44 expression system in the MCF-7 cell line combined with microarray analysis, we identified survivin (SVV) as a potential downstream transcriptional target of CD44. To test the hypothesis that SVV underpins CD44-promoted BC cell invasion, we combined molecular and pharmacologic approaches and showed that CD44 induction increased SVV expression levels, which in turn promotes BC cell invasion. Further, clinical analysis of breast tissue samples showed that SVV expression patterns paralleled those of the standard form of CD44 during breast tumor progression. More interestingly, we identified the PI3K/E2F1 pathway as a potential molecular link between HA/CD44 activation and SVV transcription. In addition to identifying SVV as a target for HA/CD44 signaling, this investigation provides a better understanding of the molecular mechanisms that underpin the novel function of SVV in breast cancer metastasis.

Original languageEnglish
Pages (from-to)555-563
Number of pages9
JournalAmerican Journal of Pathology
Volume179
Issue number2
DOIs
Publication statusPublished - Aug 2011

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Survivin is a novel target of CD44-promoted breast tumor invasion'. Together they form a unique fingerprint.

  • Cite this

    Abdraboh, M. E., Gaur, R. L., Hollenbach, A. D., Sandquist, D., Raj, M. H. G., & Ouhtit, A. (2011). Survivin is a novel target of CD44-promoted breast tumor invasion. American Journal of Pathology, 179(2), 555-563. https://doi.org/10.1016/j.ajpath.2011.04.042